Advertisement

Topics

Nuclear Medicine - Biotech, Pharma and Life Science Channel

02:37 EST 24th January 2019 | BioPortfolio

Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.

In nuclear medicine procedures, radionuclides are combined with other elements to form chemical compounds, or else combined with existing pharmaceutical compounds, to form radiopharmaceuticals. These radiopharmaceuticals, once administered to the patient, can localize to specific organs or cellular receptors.

This property of radiopharmaceuticals allows nuclear medicine the ability to image the extent of a disease process in the body, based on the cellular function and physiology, rather than relying on physical changes in the tissue anatomy. In some diseases, nuclear medicine studies can identify medical problems at an earlier stage than other diagnostic tests. 

Treatment of diseased tissue, based on metabolism or uptake or binding of a particular ligand, may also be accomplished, similar to other areas of pharmacology. However, the treatment effects of radiopharmaceuticals rely on the tissue-destructive power of short-range ionizing radiation.

In the future, nuclear medicine may provide added impetus to the field known as molecular medicine. As understanding of biological processes in the cells of living organisms expands, specific probes can be developed to allow visualization, characterization, and quantification of biologic processes at the cellular and subcellular levels.[

Source: Wikipedia

 

News Articles [38 Associated News Articles listed on BioPortfolio]

Fuji Pharma Invests in Alvotech for US$50 Million

Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2% stake in the business for approximately US$50 million. This press release...

Blue Earth Diagnostics Announces U.S. Food and Drug Administration (FDA) Filing Acceptance of Supplemental New Drug Application (sNDA) for 18F-fluciclovine PET Imaging in Glioma

– sNDA seeks to expand Axumin® (fluciclovine F 18) label for use in detection and continuing assessment in adults with glioma – Blue Earth Diagnostics, a molecular...

Eckert & Ziegler BEBIG to restructure its implant business

Press releaseInside and regulated information 30 November 2018, 7:45 (CET)  Seneffe, 30 November 2018. Today, the management of Eckert & Ziegler BEBIG SA decided that as of mid-201...

Lantheus Holdings to Present at the BMO Prescriptions for Success Healthcare Conference

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufactur...

Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan

- Alvotech gains access to the third largest pharmaceutical market in the world - Partnership gives Fuji Pharma a leading position in the Japanese biosimilar marke...

Blue Earth Diagnostics Announces 18F-Fluciclovine Research Presentation at Upcoming Society for Neuro-Oncology (SNO) Annual Scientific Meeting

Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that a presentation related to the clinical use of 18F-fluciclovine in adults with glioma will be ...

Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and IFO

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and Cutaneous and Mucosal malignant Neoplasia ...

Lantheus Holdings to Present at Upcoming Investor Conferences

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufactur...

CORAR Requests Expeditious Safe Return of Medical Isotope Production at NTP

The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), the voice of the radionuclide, radiopharmaceutical, and nuclear pharmacy industries in North America, announce...

Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting

Multiple Doses of AU-011 are Well-Tolerated, with Vision Preservation Observed at 12 to 18 Months All Patients Met Preliminary Efficacy Endpoint to Date with Evidence ...

Companies [10 Associated Companies listed on BioPortfolio]

Alpha Tau Medical

Founded in 2016, Alpha Tau Medical Ltd. is an Israeli medical device company that focuses on research, development and commercialization of the Alpha DaRT for the treatment of sol...

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) is a late stage development company engaged in the development of brachytherapy devices for therapeutic applications. AMIC's focus is o...

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“LMI”), which is a global leader in developing, manufacturing, selling and distributing ...

Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. (www.isotope.com) is the world's premier supplier of stable isotopes and stable isotope labeled compounds for research applications in structu...

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical ...

Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical...

Neoprobe Corporation and Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

KineMed, Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarkerâ...

Symbiotic Research Services

SR is a contract research organization (CRO) which is licensed to conduct research with radio labeled C-14 materials. SR has been inspected by the US-EPA and the NJ-DEP Division o...

Clinical Trials [438 Associated Clinical Trials listed on BioPortfolio]

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

This early phase I trial studies how well nivolumab and yttrium-90 work in treating patients with liver cancer who are undergoing surgical resection. Immunotherapy with monoclonal antibodi...

Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

This study will use brain PET/MRI and an investigational radioactive drug called [Zr-89]oxine to track the location of white blood cells in the body. PET/MRI will be used to visualize labe...

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

This phase Ib trial studies the dose and schedule of 177Lu-PSMA-617 and pembrolizumab in treating patients with castration-resistant prostate cancer that has spread to other places in the ...

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

This study evaluates the rate of radiological disease progression with the new 2nd generation positron emission tomography (PET) radiopharmaceutical, 18F-DCFPyL, in patients with metastati...

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Background: The disease follicular lymphoma (FL) develops when the body makes abnormal B-cells. These cells usually build up in the lymph nodes, but can also affect other parts of the bod...

Using Acupoint Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis

A total of 160 cases of nasopharyngeal carcinoma patients who met the inclusion criteria were randomly assigned to two groups. The experimental group was given acupoint massage of maxillof...

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

The sponsor wants to investigate how well the test medicine is taken up by the body when given orally (by mouth) as a tablet or capsule and as a solution for infusion (into a vein). The ca...

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [18F]DPA-714.

The primary objective of this study is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET radiopharmaceutical [18F]DPA-...

PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Gallium-68 DOTATATE is a radioactive tracer, a type of imaging drug that is labeled with a radioactive tag and injected into the body, which is approved by the U.S. Food and Drug Administr...

Pulmonary Inflammation Using FNOS PET in E-cigarette

The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called [18F]NOS. A radioactive tracer is a ty...

PubMed Articles [233 Associated PubMed Articles listed on BioPortfolio]

Highlighting protein fining residues in a model red wine.

Many studies have dealt with fining treatments, focusing on their impact on phenolic precipitation or sensory properties of the treated wines. Previous articles suggested the presence of soluble compl...

Radiopharmaceutical Therapy.

Radiopharmaceutical therapy involves the use of radionuclides that are either conjugated to tumor-targeting agents (e.g., nanoscale constructs, antibodies, peptides, and small molecules) or that conce...

Dose Optimization of Hybrid Imaging.

Hybrid imaging combines the functional and molecular imaging of positron emission computed tomography and single-photon emission computed tomography with the anatomical information available from comp...

NCRP Vision for the Future and Program Area Committee Activities in 2018.

The National Council on Radiation Protection and Measurements' (NCRP) congressional charter aligns with our vision for the future: to improve radiation protection for the public and workers. This visi...

Analysis of radioactive waste generated during the cyclotron production of 99mTc.

Past and prospective shortages of medical radioisotopes have driven recent developments in the direct production of <sup>99m</sup>Tc via the <sup>100</sup>Mo(p,2n)<sup>99...

Geopolymer technology for the solidification of simulated ion exchange resins with radionuclides.

In this study, geopolymer was applied to convert ion exchange resins contaminated with radionuclides into a solid waste form. Geopolymer has superior properties to enable the encapsulation of spent re...

Publisher Correction: Radioactive drugs emerge from the shadows to storm the market.

In the version of this article initially published, Betalutin was described as directing a radioisotope to CD45-expressing B cells; in fact, it directs it to CD37-expressing B cells. The error has bee...

Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.

Integrins play important roles in physiological and pathophysiological processes. Among the RGD-recognizing integrin subtypes, the αvβ8 receptor is emerging as an attractive target due to its involv...

Determination of human γδ T cell-mediated cytotoxicity using a non-radioactive assay system.

The adoptive transfer of immune effector cells, such as CD8 killer αβ T cells, γδ T cells, NK (natural killer) cells, and genetically-modified T cells, has been receiving increasing attention. It ...

Structural-functional modifications of the liver to chronic radioactive exposure in pygmy wood mouse (Apodemus uralensis) within the East-Urals Radioactive Trace.

The hepatic parameters (contents of glycogen, total lipids, nuclear and cytoplasmic proteins, DNA and RNA, fructose-6-phosphate, water, lipid peroxidation products, as well as activities of succinate ...

Medical and Biotech [MESH] Definitions

Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.

Uncontrolled release of radioactive material from its containment. This either threatens to, or does, cause exposure to a radioactive hazard. Such an incident may occur accidentally or deliberately.

Contamination of air with radioactive substances.

Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...